Drug development study designs have reached the danger zone

Expert Rev Clin Pharmacol. 2013 Nov;6(6):589-91. doi: 10.1586/17512433.2013.841539.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Protocols / standards*
  • Data Collection / methods
  • Data Collection / standards
  • Drug Approval / economics
  • Drug Approval / methods*
  • Medical Errors
  • Research Design / standards*
  • Research Design / trends*
  • Risk Factors
  • United States
  • United States Food and Drug Administration